Treatment of multiple myeloma with nasal spray calcitonin: a histomorphometric and biochemical study
- 1 March 1990
- journal article
- research article
- Published by Elsevier in Bone and Mineral
- Vol. 8 (3) , 231-237
- https://doi.org/10.1016/0169-6009(90)90108-r
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- One year's treatment of paget's disease of bone by synthetic salmon calcitonin as a nasal sprayJournal of Bone and Mineral Research, 1988
- Biochemical assessment of acute and chronic treatment of Paget's bone disease with calcitonin and calcium with and without biphosphonateBone, 1988
- Calcitonin-Induced Hypocalcaemia as a Possible Index of Osteoclastic Activity in Patients with Chronic Renal FailureNephron, 1987
- Biochemical assessment of bone disease in multiple myelomaClinica Chimica Acta; International Journal of Clinical Chemistry, 1984
- Quantitative histology of myeloma‐induced bone changesBritish Journal of Haematology, 1982
- Relation of Osteoclast Activating Factor Production to Extent of Bone Disease in Multiple MyelomaBritish Journal of Haematology, 1981
- Effects of Dichloromethylene Diphosphonate on Skeletal Mobilization of Calcium in Multiple MyelomaNew England Journal of Medicine, 1980
- INHIBITION OF OSTEOLYTIC BONE LESIONS BY (3-AMINO-1-HYDROXYPROPYLIDENE)-1, 1-BISPHOSPHONATE (A.P.D.)The Lancet, 1979
- A quantitative study of the effects of prolonged calcitonin treatment on alveolar bone remodelling in the golden hamsterCalcified Tissue International, 1977
- Interpretation of Serum Calcium in Patients with Abnormal Serum ProteinsBMJ, 1973